Director, Healthcare
Yaoyao Wang is a director for William Blair based in the firm’s London office. She joined William Blair's investment banking team in 2015. Prior to William Blair, she worked for PwC.
YWCA San Francisco & Marin
YWCA Chicago
English
Mandarin
Spanish (Conversational)
has been acquired by
William Blair acted as the exclusive financial advisor to HyTest, a portfolio company of Summa Equity in connection with its pending sale to Mindray (Shenzen Stock Exchange Ticker: 300760) for €545 million in total consideration.
Read more
Initial Public Offering
has been acquired by
William Blair acted as the exclusive financial advisor to Axion BioSystems in connection with its sale to Summa Equity.
Read more
has received a growth equity investment led by
has been acquired by
Initial Public Offering
Our investment bankers are 100 percent committed to your organization’s sustained success. By drawing on our deep industry and product experience as well as our dedicated global resources, we provide advisory and financing services that allow you to capitalize on today’s opportunities and anticipate tomorrow’s challenges.
More about investment banking at William Blair
William Blair’s Healthcare Services team is a trusted partner to providers, suppliers, and solutions providers across the healthcare continuum. Our knowledge of emerging healthcare trends and the nuances of reimbursement models have allowed us to help clients access capital and form valuable strategic partnerships.
More about our healthcare services expertise
William Blair is a premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*
Year William Blair was founded
Employees worldwide
Client assets
Independent and employee-owned
Offices worldwide
Companies under coverage
As of March 31, 2022
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.
This content is for informational and educational purposes only and not intended as investment advice or a recommendation to buy or sell any security. Investment advice and recommendations can be provided only after careful consideration of an investor's objectives, guidelines, and restrictions.
Copyright © 2022 William Blair & Company, L.L.C. | Privacy Terms
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures